CAS No 881681-00-1 1 -[5-(2-Fluorophenyl)-l -(pyri ne-3-ylsulfonyl)-lH-pyrrol-3-yl]-N-methylmethanamme Pharmaceutical Intermediates

1. Efficacy: Ziprasidone is effective in reducing the severity of psychotic symptoms and is the first choice of healthcare providers.
2. Fewer side effects: Compared with traditional antipsychotic drugs, ziprasidone has a lower incidence of extrapyramidal symptoms, thereby improving patient compliance.
3. Multiple Applications: In addition to schizophrenia, ziprasidone is also used to treat acute mania and mixed episodes associated with bipolar disorder.
4. Rapid onset of effect: Patients usually feel symptom relief and improved quality of life within a short period of time after taking the medicine.

     Ziprasidone hydrochloride is widely used in the pharmaceutical industry to formulate various dosage forms, including tablets and injections. Its compatibility with other excipients allows for the development of combination therapies, thereby improving the treatment of patients with complex psychiatric disorders.
     Our integrated manufacturing facilities ensure that we are able to produce Ziprasidone HCl in large quantities while maintaining stringent quality control measures. This capability enables us to meet the needs of pharmaceutical companies seeking reliable suppliers of high-quality active pharmaceutical ingredients (APIs).